BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Authors
» James Etheridge
James Etheridge
Articles
ARTICLES
Aptanomics Raises EUR7M For Peptide Aptamer-Based Platform
Nov. 6, 2002
By
James Etheridge
Avidis Closing EUR1.7M Round To Develop Peptides Technology
Nov. 6, 2002
By
James Etheridge
Aptanomics Raises EUR7M For Peptide Aptamer-Based Platform
Nov. 6, 2002
By
James Etheridge
Genome Express Unveils New Gene Discovery Technology
Oct. 30, 2002
By
James Etheridge
IDM Enters Research Agreement With Nemod On Immunotherapies
Oct. 30, 2002
By
James Etheridge
Genset Delists From Nasdaq, Closes Paris Headquarters
Oct. 30, 2002
By
James Etheridge
ExonHit Initiates Clinical Trial Of Lead Compound For ALS
Oct. 30, 2002
By
James Etheridge
ExonHit Initiates Clinical Trial Of Lead Compound For ALS
Oct. 30, 2002
By
James Etheridge
Genome Express Unveils New Gene Discovery Technology
Oct. 30, 2002
By
James Etheridge
Genset Delists From Nasdaq, Closes Paris Headquarters
Oct. 30, 2002
By
James Etheridge
View All Articles by James Etheridge
